1Lewis JJ,Leung D,Woodruff JM,et al.Retroperitoneal soft-tissue sarcoma:analysis of 500 patients treated and followed at a single institution[J].Ann Surg,1998,228(3):355-365.
2Stoeckle E,Coindre JM,Bonvalot S,et al.Prognostic factors in retroperitoneal sarcoma:a multivariate analysis of a series of 165 patient of the French Cancer Center Federation Sarcoma Group[J].Cancer,2001,92(2):359-368.
4Porter GA,Baxter NN,Pisters PW.Retroperitoneal sarcoma:a population-based analysis of epidemiology,surgery,and radiotherapy[J].Cancer,2006,106(7):1610-1616.
5Heslin MJ,Lewis JJ,Nadler E,et al.Prognostic factors associated with long-term survival for retroperitoneal sarcoma:implications for management[J].J Clin Oncol,1997,15(8):2832-2839.
6Yang JC,Chang AE,Baker AR,et al.Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity[J].J Clin Oncot,1998,16(1):197-203.
7Adjuvant chemotheapy for localised rsectable soft-tissue sarcoma of adults:meta-analysis of individual data.Sarcoma Meta-analysis Collaboration[J].Lancet,1997,350(9092):1647-1654.
8Frustaci S,Gherlinzoni F,De Paoli A,et al.Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles:results of the Italian randomized cooperative trial[J].J Clin Oncol,2001,19(5):1238-1247.
9Catton CN,O'Sullivan B,Kotwall C,et al.Outcome and prognosis in retroperitoneal soft tissue sarcoma[J].Int J Radiat Oncol Biol Phys,1994,29(5):1005-1010.
10Hassan I,Park SZ,Donohue JH,et al.Operative management of primary retroperitoneal sarcomas:a reappraisal of an institutional experiance[J].Ann Surg,2004,239(2):244-250.
二级参考文献13
1Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg,1995, 221:185-195.
2Jaques DP, Coit DG, Hajdu SI, et al. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg, 1990,212:51-59.
3Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg, 1998, 228:355-365.
4Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol, 1997, 15:2832-2839.
5Youssef E, Fontanesi F, Mott M, et al. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma:analysis of prognostic factors. Int J Radiat Oncol Biol Phys, 2002, 54:514-519.
6van Dalen T, Hoekstra, HJ, van Geel AN, et al. Locoregional recurrence of retroperitoneal soft-tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol, 2001, 27: 564-568.
7Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol, 1998, 16:197-203.
8Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys, 1994,29: 1005-1010.
9Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas: final results of a prospective randomized clinical trial. Arch Surg, 1993, 128:402-410.
10Petersen IA, Haddock MG, Konohue JH, et al. Use of intraoperative electron beam radiation therapy (IOERT) in the management of retroperitoneal and pelvic soft tissue sarcomas. Int J Radiat Oncol Biol Phys, 1996, 36 Suppl 1: 185.
4Clark MA, Fisher C, Judson L, et al. Soft-tissue sarcomas in adults[J]. N Engl J Med, 2005, 353(7): 701-711.
5Duman BB, Gunaldi M, Ercolak V, et al. Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre [J]. Asian Pac J Cancer Prev, 2012, 13(8): 4125-4128.
6Rossi CR, Nitti D, Foletto M, et al. Management of primary sar- comas of the retroperitoueum[J]. Eur J Surg Oncol, 1993, 19(4): 355-360.
7Clark MA, Fisher C, Judson I, et al. Soft-tissue sarcomas in adults[J]. N Engl J Med, 2005, 353(7): 701-711.
8Gronehi A, Frustaci S, Mercuri M, et al. Short, full-dose adju- vant chemotherapy in high-risk adult soft tissue sarcomas: a ran- domized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group[J]. J Clin Oncol, 2012, 30(8): 850-856.
9Brandts CH, Schulz C, Willich N, et al. Adjuvant therapy for re- sectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy [J]. Cancer Chemother Pharmacol, 2012, 69(3): 613-620.
10Woll PJ, Reichardt P, Le CA, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial[J]. Lancet Oncol, 2012, 13(10): 1045-1054.
